<DOC>
	<DOCNO>NCT02013232</DOCNO>
	<brief_summary>Hyperprolactinemia frequent consequence treatment typical antipsychotic agent atypical antipsychotic risperidone . Recent study suggest aripiprazole , partial dopamine agonist , reduce prolactin response antipsychotic . Thus , conduct study evaluate dose effect adjunctive treatment aripiprazole hyperprolactinemia stable schizophrenic patient maintain risperidone .</brief_summary>
	<brief_title>Adjunctive Aripiprazole Treatment Risperidone-Induced Hyperprolactinemia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Hyperprolactinemia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1. aged 1845 year fulfil Diagnostic Statistical Manual Mental Disorders ( DSMIV ) criterion ( American Psychiatric Association , 1994 ) schizophrenia ; 2. stable psychiatric condition , define take dosage risperidone least 6 week ; 3. treat risperidone monotherapy ; presence hyperprolactinemia associate risperidone . 1. major psychiatric disorder ; 2. significant concurrent medical illness , organic brain disorder , history substance alcohol abuse , mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Risperidone ;</keyword>
	<keyword>Aripiprazole ;</keyword>
	<keyword>Hyperprolactinemia ;</keyword>
	<keyword>dose effect</keyword>
</DOC>